Simple Science

Cutting edge science explained simply

# Health Sciences # Neurology

Wearable Sensors: A New Way to Track Ataxia

Wearable devices provide fresh insights into ataxia progression and treatment effectiveness.

Anoopum S Gupta, R. Manohar, F. X. Yang, C. D. Stephen, J. D. Schmahmann, N. M. Eklund

― 5 min read


Tracking Ataxia with Tracking Ataxia with Technology into ataxia and treatment progress. Wearable sensors reveal new insights
Table of Contents

Researchers are working on new treatments for diseases that affect the nervous system, particularly conditions like spinocerebellar Ataxias (SCAs) and multiple system atrophy (MSA). A major challenge in developing these treatments is the lack of effective tools to measure how the diseases progress and how well treatments work. Current methods rely on clinician-rated scales, such as the Scale for the Assessment and Rating of Ataxia (SARA). However, these scales can be inconsistent because of subjective ratings, low detail in scoring, and variations in patients' energy levels during assessments. Additionally, these scales may not accurately reflect a person's daily motor skills.

Wearable Technology for Assessment

Wearable devices, like wrist sensors with accelerometers, offer a promising solution to measure movement and track changes in people with ataxia. These sensors have been used in various tasks involving the upper limbs, such as moving the hands, and have shown they can effectively differentiate between those with ataxia and healthy individuals while also aligning well with traditional rating scales.

Similar technology has been applied to assess movements in the lower limbs and trunk to evaluate walking and balance during simple tests. Data from these sensors have demonstrated a strong ability to report changes in a person’s condition over time, showing better sensitivity than traditional rating scales.

Researchers have also found that these sensors can be used in a person's natural environment at home. By wearing sensors on their feet and lower back, people can be monitored during their daily routine. This method allows researchers to gather data without interrupting normal activities, capturing relevant movement patterns and changes in balance.

Study and Results

In a recent study, researchers tracked individuals with SCAs and MSA using Wearable Sensors over a set period. They focused on capturing natural movement behaviors and examining how these changes related to established Clinical Assessments. Participants engaged in the study from late 2019 to early 2024, providing a broad range of data.

Participants aged 18 and older were included in the study. This group consisted of individuals diagnosed with specific types of ataxia, as well as control participants without any ataxia risk factors. Participants were asked to wear devices on their wrists and ankles to collect movement data in their everyday lives.

The data was analyzed based on the frequency and quality of movement. Researchers paid close attention to the characteristics of movement, such as how strong and steady the movements were. They used this data to compare with traditional assessments and identify how wearable technology could enhance understanding of ataxia conditions.

The study found that wearable sensors could accurately measure changes in movement over time, with significant tracking of Disease Progression. The measures from wrist and ankle sensors correlated well with standard clinical assessments, confirming their value in understanding ataxia.

Exploring Submovements

An important part of the research involved analyzing smaller movements, known as submovements. These are the basic building blocks of larger actions. Researchers noted that in individuals with ataxia, these submovements tended to become smaller, slower, and less precise, indicating a progressive decline in motor function.

They observed this ongoing change not only in task-based settings but also in everyday activities at home. This finding suggests that submovement analysis can provide a detailed look into how ataxia impacts motor control over time.

Key Findings

The study highlighted several important findings:

  1. Correlation with Clinical Measures: Data from wearable sensors matched well with the results from traditional clinical assessments. This reinforces the value of using technology to gauge disease progression.

  2. Sensitivity to Change: The sensor-derived measurements were able to detect changes in a person's condition more effectively than some standard assessments, which can sometimes miss subtle declines.

  3. Reliability: Measures obtained from the sensors were consistent over time, indicating that they could be reliably used in future studies and treatment assessments.

  4. Natural Behavior Monitoring: By allowing participants to engage in normal activities while wearing the sensors, researchers gathered data that more accurately represented day-to-day function.

  5. Differentiation of Populations: The data from individuals with ataxia were consistently different from control participants, demonstrating the potential of using these sensors to identify and analyze specific ataxia types.

Future Directions

While the findings are promising, the research still has limitations. The group of individuals studied was relatively small, and more time points would be helpful to gain a deeper understanding of how ataxia progresses in each unique case.

Further investigation is needed with larger groups of individuals experiencing different types of ataxia, especially those in early stages of the disease. This could help identify early signs of motor decline and the effectiveness of treatments more rapidly.

As technology continues to advance, there is potential to develop even more refined tools that can monitor not just movement but also other aspects of daily life that may be affected by ataxia. By integrating this data with clinical assessments, researchers hope to create a comprehensive picture of the disease's impact on individuals.

Conclusion

The use of wearable sensors presents a promising new avenue for monitoring and understanding neurodegenerative diseases such as ataxia. By capturing detailed movement data in real-life settings, researchers can gain deeper insights into disease progression and treatment responses. This technology has the potential to transform how we assess and manage these conditions, improving the quality of life for those affected. The ongoing commitment to refining these methods and incorporating feedback from patients will be essential for future advancements in this field.

Original Source

Title: At-home wearables and machine learning capture motor impairment and progression in adult ataxias

Abstract: A significant barrier to developing disease-modifying therapies for spinocerebellar ataxias (SCAs) and multiple system atrophy of the cerebellar type (MSA-C) is the scarcity of tools to sensitively measure disease progression in clinical trials. Wearable sensors worn continuously during natural behavior at home have the potential to produce ecologically valid and precise measures of motor function by leveraging frequent and numerous high-resolution samples of behavior. Here we test whether movement-building block characteristics (i.e., submovements), obtained from the wrist and ankle during natural behavior at home, can sensitively capture disease progression in SCAs and MSA-C, as recently shown in amyotrophic lateral sclerosis (ALS) and ataxia telangiectasia (A-T). Remotely collected cross-sectional (n = 76) and longitudinal data (n = 27) were analyzed from individuals with ataxia (SCAs 1, 2, 3, and 6, MSA-C) and controls. Machine learning models were trained to produce composite outcome measures based on submovement properties. Two models were trained on data from individuals with ataxia to estimate ataxia rating scale scores. Two additional models, previously trained entirely on longitudinal ALS data to optimize sensitivity to change, were also evaluated. All composite outcomes from both wrist and ankle sensor data had moderate to strong correlations with ataxia rating scales and self-reported function, strongly separated ataxia and control populations, and had high within-week reliability. The composite outcomes trained on longitudinal ALS data most strongly captured disease progression over time. These data demonstrate that outcome measures based on accelerometers worn at home can accurately capture the ataxia phenotype and sensitively measure disease progression. This assessment approach is scalable and can be used in clinical or research settings with relatively low individual burden.

Authors: Anoopum S Gupta, R. Manohar, F. X. Yang, C. D. Stephen, J. D. Schmahmann, N. M. Eklund

Last Update: 2024-10-29 00:00:00

Language: English

Source URL: https://www.medrxiv.org/content/10.1101/2024.10.27.24316161

Source PDF: https://www.medrxiv.org/content/10.1101/2024.10.27.24316161.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to medrxiv for use of its open access interoperability.

Similar Articles